Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysterosalpingography Practice

• Status: Unknown status
• Trial end date: 2012-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to demonstrate that Lidocaine-Prilocaine cream decrease pain during hysterosalpingography diagnostic practice.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Consorci Sanitari de Terrassa
• Treatments: EMLA; Lidocaine; Lidocaine, Prilocaine Drug Combination; Prilocaine

Criteria

Inclusion Criteria:

• patients that must perform a hysterosalpingography

• acceptance to participate in the study signed informed consent

Exclusion Criteria:

• hypersensitivity or allergy to anesthetics

• refusal of the patient

• patients under age 18 years old and pregnant

• unbearable pain that involves other analgesic measures